Cipla announced on December 4, 2025, the successful completion of its 100% acquisition of securities in Inzpera Healthsciences Limited (“Inzpera”). With this acquisition, Inzpera has become a wholly-owned subsidiary of Cipla. The acquisition marks a strategic expansion for Cipla, further strengthening its presence in the healthcare sector. The company has notified about this acquisition, dated November 3, 2025.
Inzpera Now a Wholly Owned Subsidiary
As of December 4, 2025, Cipla has finalized the acquisition of 100% stake in Inzpera Healthsciences Limited (“Inzpera”). Following the completion of this acquisition, Inzpera is now officially recognized as a wholly-owned subsidiary of Cipla.
Source: BSE
